Drug Profile
Insulin injection - Eli Lilly and Company
Alternative Names: ENTUZITY KwikPenLatest Information Update: 26 Dec 2022
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diabetes mellitus
Most Recent Events
- 16 Dec 2022 Eli Lily and EVA Pharma enters into manufacturing and supply agreement for the development of Insulin in Africa
- 20 Oct 2017 Launched for Diabetes mellitus (in adults, in children) in Canada (SC)
- 27 Jul 2017 Registered for Diabetes mellitus in Canada (SC) (Eli Lilly Canada website, December 2017)